https://pepgra.com/blog/relevant-medical-databases-and-search-engines-for-periodic-literature-screening/2020-03-25T11:24:52+00:00https://pepgra.com/blog/new-medical-device-regulation-implications-for-medical-device-manufacturers/2020-03-25T11:23:29+00:00https://pepgra.com/blog/challenges-and-solutions-to-pharmacovigilance-literature-screening/2020-03-25T11:24:27+00:00https://pepgra.com/blog/e-dossier-submission-regulatory-and-procedural-guidance/2020-03-25T11:24:23+00:00https://pepgra.com/blog/overview-of-the-main-differences-during-new-product-development-between-medical-devices-and-medicines/2020-03-25T11:24:13+00:00https://pepgra.com/blog/preparing-for-the-future-the-new-european-union-medical-devices-regulation/2020-03-25T11:24:17+00:00https://pepgra.com/blog/medical-device-classification-in-the-european-union/2020-03-25T11:23:35+00:00https://pepgra.com/blog/output-of-the-post-market-surveillance-pms-plan/2020-03-27T12:16:17+00:00https://pepgra.com/blog/medical-literature-monitoring-and-entering-negative-reaction-reports/2020-03-31T09:40:40+00:00https://pepgra.com/blog/periodic-safety-update-reports-psurs/2020-04-19T17:30:03+00:00https://pepgra.com/blog/clinical-trial-design-and-artificial-intelligence/2020-04-25T06:48:26+00:00https://pepgra.com/blog/pharmacovigilance/pharmaceutical-legislation-on-notice-to-applicants-and-regulatory-guidelines-for-medicinal-products-for-human-use/2020-05-22T07:43:14+00:00https://pepgra.com/blog/medical-devices/risk-managements-documents-required-for-the-market-placement-of-a-medical-device-compared-with-a-medicinal-product/2020-05-12T12:51:38+00:00https://pepgra.com/blog/clinical-trail-design/challenges-in-the-study-design-conduct-and-analysis-of-randomized-clinical-trials/2020-06-24T07:20:48+00:00https://pepgra.com/blog/post-marketing/post-authorization-stage-of-product-cycle/2021-01-08T07:22:08+00:00https://pepgra.com/blog/medical-literature/challenges-and-opportunities-in-software-driven-medical-sciences/2020-06-30T13:20:46+00:00https://pepgra.com/blog/clinical-trail-design/clinical-trial-protocol-writing-challenges-and-guidelines/2020-07-07T10:25:16+00:00https://pepgra.com/blog/clinical-writing/role-of-biostatistician-and-biostatistical-programming-in-epidemiological-studies/2020-07-17T08:05:06+00:00https://pepgra.com/blog/clinical-writing/estimation-of-sample-size-and-power-analysis-for-clinical-research-studies/2020-07-31T04:22:38+00:00https://pepgra.com/blog/clinical-writing/guidelines-on-virtuous-pharmacovigilance-practices/2020-12-18T12:14:14+00:00https://pepgra.com/blog/medical-literature/recent-trends-in-genomic-biomarkers/2021-02-06T10:03:34+00:00https://pepgra.com/blog/clinical-trail-design/post-authorization-studies-for-clinical-research-purposes/2021-02-06T10:02:43+00:00https://pepgra.com/blog/clinical-writing/uses-of-patient-registries-for-clinical-studies-to-acquire-unwavering-data/2021-02-06T10:01:42+00:00https://pepgra.com/blog/clinical-writing/practical-guidance-for-biomarkers-into-early-phase-clinical-research-purposes/2021-02-06T10:00:48+00:00https://pepgra.com/blog/healthcare/how-electronic-health-records-transforms-the-healthcare-sectors/2021-02-06T09:59:55+00:00https://pepgra.com/blog/clinical-writing/how-regulatory-writing-plays-an-essential-role-in-clinical-research/2021-02-06T09:59:05+00:00https://pepgra.com/blog/medical-devices/reporting-side-effects-for-any-medical-products-devices-or-drugs/2021-02-06T09:58:15+00:00https://pepgra.com/blog/clinical-trail-design/literature-review-of-drug-development-using-real-world-evidence/2021-02-06T09:57:20+00:00https://pepgra.com/blog/clinical-trail-design/how-to-identify-and-recruit-patients-for-secured-clinical-trials-top-10-tips/2021-02-06T09:54:35+00:00https://pepgra.com/blog/clinical-trail-design/what-are-the-ema-guidelines-for-clinical-trial-management/2021-02-06T09:53:26+00:00https://pepgra.com/blog/medical-literature/top-tips-for-a-medical-writer-to-prepare-a-successful-nda/2021-02-10T04:09:51+00:00https://pepgra.com/blog/medical-devices/significances-and-difficulties-of-e-labelling-in-the-medical-device-industries/2021-02-15T08:05:30+00:00https://pepgra.com/blog/clinical-writing/how-to-manage-risks-in-clinical-studies-top-5-tips/2021-02-17T08:39:38+00:00https://pepgra.com/blog/food-and-drug/challenges-faced-during-fda-device-approval-process/2021-02-19T07:02:43+00:00https://pepgra.com/blog/clinical-trail-design/uses-and-implementation-process-of-electronic-data-capture-edc-in-clinical-trials/2021-02-24T05:52:08+00:00https://pepgra.com/blog/literature/literature-screening-and-risk-management-for-biosimilars-challenges-and-preventive-measures/2021-02-27T08:16:33+00:00https://pepgra.com/blog/literature/evaluating-the-results-of-the-literature-search-and-screening/2022-02-28T09:47:33+00:00https://pepgra.com/blog/healthcare/what-is-the-healthcare-impact-of-data-collection/2022-03-01T04:33:42+00:00https://pepgra.com/blog/medical-devices/guidelines-for-post-market-surveillance-of-medical-devices/2022-03-02T12:12:08+00:00https://pepgra.com/blog/medical-devices/regulatory-problems-about-biomaterials-and-medical-devices/2022-03-03T07:20:15+00:00